DE69631104D1 - 5,6,7,8-Tetrahydronaphto(2,3-b)furan- und indano(5,6-b)furan-amino-Verbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen - Google Patents

5,6,7,8-Tetrahydronaphto(2,3-b)furan- und indano(5,6-b)furan-amino-Verbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Info

Publication number
DE69631104D1
DE69631104D1 DE69631104T DE69631104T DE69631104D1 DE 69631104 D1 DE69631104 D1 DE 69631104D1 DE 69631104 T DE69631104 T DE 69631104T DE 69631104 T DE69631104 T DE 69631104T DE 69631104 D1 DE69631104 D1 DE 69631104D1
Authority
DE
Germany
Prior art keywords
furan
tetrahydronaphto
indano
processes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69631104T
Other languages
English (en)
Other versions
DE69631104T2 (de
Inventor
Jean-Louis Peglion
Joel Vian
Aimee Dessinges
Mark Millan
Valerie Audinot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of DE69631104D1 publication Critical patent/DE69631104D1/de
Publication of DE69631104T2 publication Critical patent/DE69631104T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69631104T 1995-09-29 1996-09-26 5,6,7,8-Tetrahydronaphto(2,3-b)furan- und Indano(5,6-b)furan-amino-Verbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen Expired - Fee Related DE69631104T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9511446 1995-09-29
FR9511446A FR2739379B1 (fr) 1995-09-29 1995-09-29 Nouveaux composes amines de 5,6,7,8-tetrahydronaphto(2,3-b) furane et d'indano(5,6-b)furane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE69631104D1 true DE69631104D1 (de) 2004-01-29
DE69631104T2 DE69631104T2 (de) 2004-09-02

Family

ID=9483043

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631104T Expired - Fee Related DE69631104T2 (de) 1995-09-29 1996-09-26 5,6,7,8-Tetrahydronaphto(2,3-b)furan- und Indano(5,6-b)furan-amino-Verbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Country Status (15)

Country Link
US (1) US5665765A (de)
EP (1) EP0765877B1 (de)
JP (1) JPH09110855A (de)
CN (1) CN1075067C (de)
AT (1) ATE256675T1 (de)
AU (1) AU707883B2 (de)
CA (1) CA2186337C (de)
DE (1) DE69631104T2 (de)
DK (1) DK0765877T3 (de)
ES (1) ES2213171T3 (de)
FR (1) FR2739379B1 (de)
NO (1) NO314501B1 (de)
NZ (1) NZ299465A (de)
PT (1) PT765877E (de)
ZA (1) ZA968167B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7216866B2 (en) * 2003-04-28 2007-05-15 Kyocera Mita Corporation Sheet transport path switching mechanism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470990A (en) * 1983-03-14 1984-09-11 Ayerst, Mckenna & Harrison Inc. 6,7,8,9-Tetrahydronaphtho(1,2-B)furan-8-amine derivatives and their use as dopamine receptor stimulants
FR2613365B1 (fr) * 1987-04-01 1989-07-28 Adir Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2613364B1 (fr) * 1987-04-01 1989-06-09 Adir Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2725985B1 (fr) * 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ES2213171T3 (es) 2004-08-16
CN1150151A (zh) 1997-05-21
PT765877E (pt) 2004-04-30
FR2739379B1 (fr) 1997-10-24
ATE256675T1 (de) 2004-01-15
DE69631104T2 (de) 2004-09-02
DK0765877T3 (da) 2004-04-19
NZ299465A (en) 1997-06-24
NO964072D0 (no) 1996-09-27
CA2186337C (fr) 2002-01-01
ZA968167B (en) 1997-05-02
FR2739379A1 (fr) 1997-04-04
AU6589796A (en) 1997-04-10
NO964072L (no) 1997-04-01
NO314501B1 (no) 2003-03-31
AU707883B2 (en) 1999-07-22
EP0765877B1 (de) 2003-12-17
EP0765877A1 (de) 1997-04-02
CA2186337A1 (fr) 1997-03-30
JPH09110855A (ja) 1997-04-28
CN1075067C (zh) 2001-11-21
US5665765A (en) 1997-09-09

Similar Documents

Publication Publication Date Title
MX9203150A (es) Nuevos esteres de acidos tienilcarboxilicos de aminoalcoholes, sus productos de cuaternizacion y las composiciones farmaceuticas que los contienen.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ATE50983T1 (de) Oberflaechenaktive n-(omega, omega-1-dialkoxy)und n-(omega, omega-1-dialkenoxy)-alk-1-yl-n,n,ntrisubstituierte ammoniumverbindungen, deren herstellung und sie enthaltende pharmazeutische formulierungen.
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
SE8800207D0 (sv) Nya aminer, deras anvendning och framstellning
FR2695387B1 (fr) Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ES2088241T3 (es) Nuevos esteroides que comprenden en posicion 17 un radical metileno-lactona, su procedimiento y productos intermedios de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ES2091509T3 (es) Procedimiento para la obtencion de derivados de isopreno.
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE69631104D1 (de) 5,6,7,8-Tetrahydronaphto(2,3-b)furan- und indano(5,6-b)furan-amino-Verbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
ES2095714T3 (es) Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen.
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE101610T1 (de) Indol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE57913T1 (de) Catechinamide, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zubereitung.
MX9300136A (es) Alfa-aril-alfa-hidroxi-beta-imidazolinil-propionamidas, procedimiento para su obtencion y medicamentos que las contienen.
ES2091670T3 (es) Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2123038T3 (es) Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee